SCNX Fundamental Analysis - SCIENTURE HOLDINGS INC

Fundamental Rating

SCNX gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 36 industry peers in the Health Care Technology industry. SCNX has a bad profitability rating. Also its financial health evaluation is rather negative. SCNX does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year SCNX has reported negative net income.

SCNX had a negative operating cash flow in the past year.

SCNX had negative earnings in 4 of the past 5 years.

SCNX had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

SCNX's Return On Assets of -14.33% is in line compared to the rest of the industry. SCNX outperforms 52.78% of its industry peers.

Looking at the Return On Equity, with a value of -18.78%, SCNX is in line with its industry, outperforming 55.56% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-14.33%
ROE	-18.78%
ROIC	N/A

ROA(3y)-75.75%

ROA(5y)-69.08%

ROE(3y)-1244.95%

ROE(5y)-781.05%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 4.56%, SCNX is doing worse than 83.33% of the companies in the same industry.

SCNX's Gross Margin has declined in the last couple of years.

SCNX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	4.56%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-54.95%

GM growth 5Y-41.74%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

SCNX does not have a ROIC to compare to the WACC, probably because it is not profitable.

SCNX has more shares outstanding than it did 1 year ago.

The number of shares outstanding for SCNX has been increased compared to 5 years ago.

Compared to 1 year ago, SCNX has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -0.59, we must say that SCNX is in the distress zone and has some risk of bankruptcy.

With a Altman-Z score value of -0.59, SCNX perfoms like the industry average, outperforming 41.67% of the companies in the same industry.

SCNX has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.

SCNX has a better Debt to Equity ratio (0.02) than 61.11% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.02
Debt/FCF	N/A
Altman-Z	-0.59

ROIC/WACCN/A

WACC10.16%

2.3 Liquidity

SCNX has a Current Ratio of 1.05. This is a normal value and indicates that SCNX is financially healthy and should not expect problems in meeting its short term obligations.

SCNX's Current ratio of 1.05 is on the low side compared to the rest of the industry. SCNX is outperformed by 69.44% of its industry peers.

A Quick Ratio of 1.05 indicates that SCNX should not have too much problems paying its short term obligations.

SCNX has a worse Quick ratio (1.05) than 69.44% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.05
Quick Ratio	1.05

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

SCNX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.04%.

SCNX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -97.79%.

Measured over the past years, SCNX shows a very negative growth in Revenue. The Revenue has been decreasing by -55.05% on average per year.

EPS 1Y (TTM)5.04%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-102.01%

Revenue 1Y (TTM)-97.79%

Revenue growth 3Y-76.01%

Revenue growth 5Y-55.05%

Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SCNX. In the last year negative earnings were reported.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 141.51%, SCNX is a good candidate for dividend investing.

In the last 3 months the price of SCNX has falen by -20.13%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.

Compared to an average industry Dividend Yield of 31.47, SCNX pays a better dividend. On top of this SCNX pays more dividend than 100.00% of the companies listed in the same industry.

SCNX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.39.

		Industry Rank	Sector Rank
Dividend Yield	141.51%

5.2 History

SCNX is new to the dividend game and has less than 3 years of track record.

Dividend Growth(5Y)N/A

Div Incr Years0

Div Non Decr Years0

5.3 Sustainability

SCNX has negative earnings and hence a negative payout ratio. The dividend may be in danger.

DP-14.35%

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

SCIENTURE HOLDINGS INC

NASDAQ:SCNX (6/11/2025, 8:17:56 PM)

After market: 1.1 -0.09 (-7.56%)

1.19

+0.04 (+3.48%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Technology

Earnings (Last)04-21 2025-04-21/amc

Earnings (Next)06-24 2025-06-24

Inst Owners1.85%

Inst Owner Change18.21%

Ins Owners33.22%

Ins Owner ChangeN/A

Market Cap15.61M

Analysts82.86

Price TargetN/A

Short Float %0.78%

Short Ratio0.28

Dividend

		Industry Rank	Sector Rank
Dividend Yield	141.51%

Yearly Dividend3.08

Dividend Growth(5Y)N/A

DP-14.35%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	106.21
P/FCF	N/A
P/OCF	N/A
P/B	0.19
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-3.7

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.54

FCFYN/A

OCF(TTM)-0.54

OCFYN/A

SpS0.01

BVpS6.19

TBVpS-1.27

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-14.33%
ROE	-18.78%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	4.56%
FCFM	N/A

ROA(3y)-75.75%

ROA(5y)-69.08%

ROE(3y)-1244.95%

ROE(5y)-781.05%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-54.95%

GM growth 5Y-41.74%

F-Score1

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0.02
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.05
Quick Ratio	1.05
Altman-Z	-0.59

F-Score1

WACC10.16%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)5.04%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-102.01%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-97.79%

Revenue growth 3Y-76.01%

Revenue growth 5Y-55.05%

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y0.79%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-252.2%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-381.64%

OCF growth 3YN/A

OCF growth 5YN/A

SCIENTURE HOLDINGS INC (SCNX) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens